Correlation Between Enliven Therapeutics and Sellas Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Sellas Life Sciences, you can compare the effects of market volatilities on Enliven Therapeutics and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Sellas Life.

Diversification Opportunities for Enliven Therapeutics and Sellas Life

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Enliven and Sellas is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Sellas Life go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Sellas Life

Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Sellas Life. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.09 times less risky than Sellas Life. The stock trades about -0.19 of its potential returns per unit of risk. The Sellas Life Sciences is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  117.00  in Sellas Life Sciences on September 3, 2024 and sell it today you would lose (4.00) from holding Sellas Life Sciences or give up 3.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Enliven Therapeutics  vs.  Sellas Life Sciences

 Performance 
       Timeline  
Enliven Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Sellas Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sellas Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Enliven Therapeutics and Sellas Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enliven Therapeutics and Sellas Life

The main advantage of trading using opposite Enliven Therapeutics and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.
The idea behind Enliven Therapeutics and Sellas Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges